Testing Choices: From the standard to the extraordinary
Test | Test Name |
---|---|
0568B | Benzodiazepines Screen, Blood |
0568FL | Benzodiazepines Screen, Fluid |
0568SP | Benzodiazepines Screen, Serum/Plasma |
0568U | Benzodiazepines Screen, Urine |
0771B | Brorphine, Blood |
0771SP | Brorphine, Serum/Plasma |
0771U | Brorphine, Urine |
2626B | Bath Salts Panel (Qualitative), Blood |
2626SP | Bath Salts Panel (Qualitative), Serum/Plasma |
2626U | Bath Salts Panel (Qualitative), Urine |
6922H | Benzodiazepines Screen, Hair |
8891OF | Benzodiazepines Panel (Qualitative), Oral Fluid (Saliva) |
9329B | Benzodiazepines Panel, Blood |
9329FL | Benzodiazepines Panel, Fluid |
9329ME | Benzodiazepines Panel (Qualitative), Meconium |
9329SP | Benzodiazepines Panel, Serum/Plasma |
9329TI | Benzodiazepines Panel, Tissue |
9329U | Benzodiazepines Panel, Urine |
9351UC | Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |